-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services
Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services
Furthermore, longitudinal studies have shown that most cognitively normal Aβ-positive individuals never develop clinical dementia
The causes of dementia are increasingly recognized as systemic
In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique
In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique
The results showed that 15 non-Aβ/non-tau-related proteins were associated with cognitive decline and dementia, were consistently identified in both cohorts, and were not explained by known dementia risk factors
The levels of six of these proteins can be modulated by drugs currently approved to treat other diseases
The levels of six of these proteins can be modulated by drugs currently approved to treat other diseases
This study identified several plasma proteins associated with cognitive decline and long-term risk of dementia in people without dementia
references:
references:Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
https://doi.
org/10.
1002/alz.
12419 Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
https://doi.
org/10.
1002/alz.
12419
Leave a comment here